Eraquell Tabs, Ivermectin 20 mg, Chewable Tablets for Horses
Country: Грчка
Језик: Енглески
Извор: HMA (Heads of Medicines Agencies)
Карактеристике производа
(SPC)
16-03-2012
Неки документи за овај производ тренутно нису доступни, можете послати захтев нашој служби за кориснике и ми ћемо вас обавестити чим их будемо могли добити.
Пошаљите упит.
Пошаљите упит.
Активни састојак:
ivermectin 20 mg
Доступно од:
Virbac S.A.
АТЦ код:
QP54AA01
Фармацеутски облик:
Tablet
Терапеутска група:
ivermectin
Терапеутска област:
Horses
Датум одобрења:
2010-06-30
Карактеристике производа
Issued 11/09/2009
– AN 00984/2008
1/7
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Eraquell Tabs, 20 mg Chewable tablets for Horses
Equimel Tabs, 20 mg Chewable tablets for Horses (ES, PT)
Eraquell vet., 20 mg Chewable tablets for Horses (DK, FI, IS, NO, SE)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet of 3300 mg contains:
ACTIVE SUBSTANCE
Ivermectin ..............................................................................
20
mg
For full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet.
White, circular, biconcave tablet with brown spots.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of nematode and arthropod infestations, due to adult and immature roundworms and
bots in horses:
NEMATODES
Large-strongyles:
_Strongylus vulgaris _(adult and arterial larvae)
_Strongylus edentatus _(adult and L4 tissue larval stages)_ _
_Strongylus equinus _(adult and L4 larval stage)_ _
_Triodontophorus _spp._ _(adult)_ _
Small-strongyles:
Cyathostomum (adult and non-encysted mucosal larvae)_: Cylicocyclus _spp._, Cylicostephanus _
spp., _Gyalocephalus _spp.
Parascaris: _Parascaris equorum _(adult and larvae)_. _
Oxyuris: _Oxyuris equi _(adult and larvae)_. _
Trichostrongylus: _Trichostrongylus axei _(adult)_. _
DIPTERAN INSECTS:_ Gasterophilus _spp._ _(larvae).
Issued 11/09/2009
– AN 00984/2008
2/7
4.3 CONTRAINDICATIONS
Do not use in foals under 2 weeks of age.
Do not use in horses known to be hypersensitive to the active ingredient or any of the other ingredients.
4.4
SPECIAL WARNINGS FOR TARGET SPECIES
Care should be
Прочитајте комплетан документ
